tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

PODDInsulet Corporation

Health care · Medical Instruments · Nasdaq

Insulet Corporation (“we” or the “Company”) is primarily engaged in the development, manufacture, and sale of its proprietary continuous insulin delivery systems for people with insulin-dependent diabetes. 10-K, Item 1

Employees
5,400
Headquarters
Acton, MA
CEO
Ashley McEvoy
Next results
around Feb 17, 2027
Compare with peers → Embed

From 2021 to 2025, CEO pay as reported rose 230% while net income rose 1371%. $100 in the shares at the start of the table was worth $111 at the end (peer group: $99). CEO pay over the 5 years: $94.0M.

Fiscal year toCEOCEO pay (reported) CEO pay (actually paid) Other executives, average$100 becamePeer groupNet income Adjusted revenue
Dec 31, 2025Ashley McEvoy $32.1M-$6.9M $3.8M $111$99 $247.1M $2.7B
Dec 31, 2024James Hollingshead $13.3M$32.7M $3.3M $102$81 $418.3M $2.1B
Dec 31, 2023James Hollingshead $12.4M$12.8M $2.8M $85$82 $206.3M $1.7B
Dec 31, 2022James Hollingshead $26.5M$29.6M $3.4M $115$77 $4.6M $1.3B
Dec 31, 2021Shacey Petrovic $9.7M$9.1M $2.6M $104$96 $16.8M $1.1B

Pay versus performance table of the proxy statement (DEF 14A) filed Apr 6, 2026, as tagged by the company in XBRL. Open the proxy ↗

Work on PODD in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/PODD/export.csv") into a cell.